Axovant in-licenses two new gene therapies, shares up 6% after hours [Seeking Alpha]
Axon Enterprise, Inc. (AXON)
Last axon enterprise, inc. earnings: 2/7 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.axovant.com/investors/sec-filings
Company Research
Source: Seeking Alpha
Axovant in-licenses two new gene therapies, shares up 6% after hoursAxovant Sciences (NASDAQ:AXON) is up6% after hours in response to itsannouncement that it has secured exclusive global rights to two gene therapy programs from the University of Massachusetts Medical School. The candidates will potentially treat two inherited enzyme deficiency disorders calledGMI gangliosidosis, also known as Landing disease, andGM2 gangliosidosis which includes Tay-Sachs disease and Sandhoff disease.Under the term of the license agreement, UMass Med School will receive undisclosed development, regulatory and commercial milestones.Both gene therapies, AXO-AAV-GM1 and AXO-AAV-GM2, are designed to introduce function copies of the respective genes that encode the defective or absent enzymes.The GM1 therapy should enter the clinic in H1 2019 with preliminary data expected in H2 2019. The first patient has been dosed with GM2 with initial data expected next quarter.See all stocks on the move »Now read:Axov
Show less
Read more
Impact Snapshot
Event Time:
AXON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXON alerts
High impacting Axon Enterprise, Inc. news events
Weekly update
A roundup of the hottest topics
AXON
News
- Axon Enterprise (AXON) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise Insiders Placed Bullish Bets Worth US$8.74m [Yahoo! Finance]Yahoo! Finance
- Earnings Growth & Price Strength Make Axon Enterprise (AXON) a Stock to Watch [Yahoo! Finance]Yahoo! Finance
- Axon Enterprise, Inc. (NASDAQ: AXON) had its price target raised by analysts at JPMorgan Chase & Co. from $330.00 to $365.00. They now have an "overweight" rating on the stock.MarketBeat
- Axon Enterprise (AXON) Banks on Solid Product Demand Amid Risks [Yahoo! Finance]Yahoo! Finance
AXON
Earnings
- 2/27/24 - Beat
AXON
Sec Filings
- 4/15/24 - Form DEFA14A
- 4/15/24 - Form DEFA14A
- 4/2/24 - Form 4
- AXON's page on the SEC website